GLP-1 Use Linked to Lower Colon Cancer Risk vs Aspirin

(MedPage Today) — SAN FRANCISCO — Patients with a history of GLP-1 receptor agonist treatment had a significantly lower risk of developing colorectal cancer (CRC) as compared with those who took aspirin, according to a retrospective study reported…